动物用镇静剂的全球市场:2022年～2026年

全球动物用镇静剂的市场规模在2022年～2026年间，预测将成长到1亿9,096万美元，在预测期间内预计将以5.85％的年复合成长率成长。

市场成长的主要因素有动物疾病的流行、医学研究中动物使用的增加以及对研发活动的投资增加。

本报告提供全球动物用镇静剂市场相关调查分析，提供整体分析，市场规模与预测，趋势，成长促进因素，课题，及约25家供应商的供应商分析。

目录

第1章 摘要整理

• 市场概要

第2章 市场形势

• 市场生态系统

第3章 市场规模

• 市场定义
• 市场区隔分析
• 市场规模(2021年)
• 市场预测:2021年～2026年的预测

第4章 波特的五力分析

• 五力的摘要
• 买方议价能力
• 供给企业谈判力
• 新加入厂商业者的威胁
• 替代品的威胁
• 对手的威胁
• 市场情况

第5章 各类型的市场区隔

• 市场区隔
• 各类型的比较
• 非口服:市场规模与预测(2021年～2026年)
• 口服:市场规模与预测(2021年～2026年)
• 各类型的市场机会

第6章 客户形势

• 客户形势概要

第7章 各地区的形势

• 各地区的市场区隔
• 各地区的比较
• 北美:市场规模与预测(2021年～2026年)
• 欧洲:市场规模与预测(2021年～2026年)
• 亚洲:市场规模与预测(2021年～2026年)
• 其他地区(ROW):市场规模与预测(2021年～2026年)
• 美国:市场规模与预测(2021年～2026年)
• 德国:市场规模与预测(2021年～2026年)
• 英国:市场规模与预测(2021年～2026年)
• 加拿大:市场规模与预测(2021年～2026年)
• 中国:市场规模与预测(2021年～2026年)
• 各地区形势的市场机会

第8章 促进因素·课题·趋势

• 推动市场要素
• 市场课题
• 推动因素与课题的影响
• 市场趋势

第9章 业者情势

• 概要
• 业者情势
• 混乱形势
• 产业的风险

第10章 供应商分析

• 交易厂商
• 供应商的市场定位
• Bayer AG
• C. H. Boehringer Sohn AG and Co. KG
• Ceva Sante Animale
• Dechra Pharmaceuticals Plc
• Elanco Animal Health Inc.
• Merck KGaA
• Orion Corp.
• Ouro Fino Saude Animal Group
• Virbac Group
• Zoetis Inc.

第11章 附录

Technavio has been monitoring the animal sedative market and it is poised to grow by $ 190.96 mn during 2022-2026, accelerating at a CAGR of 5.85% during the forecast period. Our report on the animal sedative market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis of the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of animal diseases, growing applications of animals in medical research, and growing investment in R and D activities.

The animal sedative market analysis includes type segment and geographic landscape.

Technavio's animal sedative market is segmented as below:

By Type

• Parenteral
• Oral

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the increasing adoption of pet animals as one of the prime reasons driving the animal sedative market growth during the next few years. Also, rising expenditure on veterinary care and enhancing the quality of care in animals during diagnosis and surgical procedures will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the animal sedative market covers the following areas:

• Animal sedative market sizing
• Animal sedative market forecast
• Animal sedative market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading animal sedative market vendors that include Akorn Operating Co. LLC, AmerisourceBergen Corp, Bayer AG, Bimeda Inc., C. H. Boehringer Sohn AG, and Co. KG, Ceva Sante Animale, Chanelle Pharma Group, Dechra Pharmaceuticals Plc, Elanco Animal Health Inc., Jurox Pty Ltd., Konig SA, Laboratorios Richmond, Merck KGaA, Modern Veterinary Therapeutics LLC, Randlab Pty Ltd., Troy Laboratories Pty Ltd., Virbac Group, Zoetis Inc., Orion Corp., and Ouro Fino Saude Animal Group. Also, the animal sedative market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary - Chart on Market Overview
• Exhibit 02: Executive Summary - Data Table on Market Overview
• Exhibit 03: Executive Summary - Chart on Global Market Characteristics
• Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
• Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
• Exhibit 06: Executive Summary - Chart on Incremental Growth
• Exhibit 07: Executive Summary - Data Table on Incremental Growth
• Exhibit 08: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 09: Parent market
• Exhibit 10: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 11: Offerings of vendors included in the market definition
• 3.2 Market segment analysis
• Exhibit 12: Market segments
• 3.3 Market size 2021
• 3.4 Market outlook: Forecast for 2021-2026
• Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
• Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
• Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
• Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

• 4.1 Five forces summary
• Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
• 4.2 Bargaining power of buyers
• Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
• 4.3 Bargaining power of suppliers
• Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
• 4.4 Threat of new entrants
• Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
• 4.5 Threat of substitutes
• Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
• 4.6 Threat of rivalry
• Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
• 4.7 Market condition
• Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Type

• 5.1 Market segments
• Exhibit 24: Chart on Type - Market share 2021-2026 (%)
• Exhibit 25: Data Table on Type - Market share 2021-2026 (%)
• 5.2 Comparison by Type
• Exhibit 26: Chart on Comparison by Type
• Exhibit 27: Data Table on Comparison by Type
• 5.3 Parenteral - Market size and forecast 2021-2026
• Exhibit 28: Chart on Parenteral - Market size and forecast 2021-2026 ($ million)
• Exhibit 29: Data Table on Parenteral - Market size and forecast 2021-2026 ($ million)
• Exhibit 30: Chart on Parenteral - Year-over-year growth 2021-2026 (%)
• Exhibit 31: Data Table on Parenteral - Year-over-year growth 2021-2026 (%)
• 5.4 Oral - Market size and forecast 2021-2026
• Exhibit 32: Chart on Oral - Market size and forecast 2021-2026 ($ million)
• Exhibit 33: Data Table on Oral - Market size and forecast 2021-2026 ($ million)
• Exhibit 34: Chart on Oral - Year-over-year growth 2021-2026 (%)
• Exhibit 35: Data Table on Oral - Year-over-year growth 2021-2026 (%)
• 5.5 Market opportunity by Type
• Exhibit 36: Market opportunity by Type ($ million)

6 Customer Landscape

• 6.1 Customer landscape overview
• Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

• 7.1 Geographic segmentation
• Exhibit 38: Chart on Market share By Geographical Landscape 2021-2026 (%)
• Exhibit 39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
• 7.2 Geographic comparison
• Exhibit 40: Chart on Geographic comparison
• Exhibit 41: Data Table on Geographic comparison
• 7.3 North America - Market size and forecast 2021-2026
• Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
• Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
• Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
• Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
• 7.4 Europe - Market size and forecast 2021-2026
• Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
• Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
• 7.5 Asia - Market size and forecast 2021-2026
• Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
• Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
• Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
• Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
• 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
• Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
• Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
• 7.7 US - Market size and forecast 2021-2026
• Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
• Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
• Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
• Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
• 7.8 Germany - Market size and forecast 2021-2026
• Exhibit 62: Chart on Germany - Market size and forecast 2021-2026 ($ million)
• Exhibit 63: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
• Exhibit 64: Chart on Germany - Year-over-year growth 2021-2026 (%)
• Exhibit 65: Data Table on Germany - Year-over-year growth 2021-2026 (%)
• 7.9 UK - Market size and forecast 2021-2026
• Exhibit 66: Chart on UK - Market size and forecast 2021-2026 ($ million)
• Exhibit 67: Data Table on UK - Market size and forecast 2021-2026 ($ million)
• Exhibit 68: Chart on UK - Year-over-year growth 2021-2026 (%)
• Exhibit 69: Data Table on UK - Year-over-year growth 2021-2026 (%)
• 7.10 Canada - Market size and forecast 2021-2026
• Exhibit 70: Chart on Canada - Market size and forecast 2021-2026 ($ million)
• Exhibit 71: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
• Exhibit 72: Chart on Canada - Year-over-year growth 2021-2026 (%)
• Exhibit 73: Data Table on Canada - Year-over-year growth 2021-2026 (%)
• 7.11 China - Market size and forecast 2021-2026
• Exhibit 74: Chart on China - Market size and forecast 2021-2026 ($ million)
• Exhibit 75: Data Table on China - Market size and forecast 2021-2026 ($ million)
• Exhibit 76: Chart on China - Year-over-year growth 2021-2026 (%)
• Exhibit 77: Data Table on China - Year-over-year growth 2021-2026 (%)
• 7.12 Market opportunity By Geographical Landscape
• Exhibit 78: Market opportunity By Geographical Landscape ($ million)

8 Drivers, Challenges, and Trends

• 8.1 Market drivers
• 8.2 Market challenges
• 8.3 Impact of drivers and challenges
• Exhibit 79: Impact of drivers and challenges in 2021 and 2026
• 8.4 Market trends

9 Vendor Landscape

• 9.1 Overview
• 9.2 Vendor landscape
• Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
• 9.3 Landscape disruption
• Exhibit 81: Overview on factors of disruption
• 9.4 Industry risks
• Exhibit 82: Impact of key risks on business

10 Vendor Analysis

• 10.1 Vendors covered
• Exhibit 83: Vendors covered
• 10.2 Market positioning of vendors
• Exhibit 84: Matrix on vendor position and classification
• 10.3 Bayer AG
• Exhibit 85: Bayer AG - Overview
• Exhibit 86: Bayer AG - Business segments
• Exhibit 87: Bayer AG - Key offerings
• Exhibit 88: Bayer AG - Segment focus
• 10.4 C. H. Boehringer Sohn AG and Co. KG
• Exhibit 89: C. H. Boehringer Sohn AG and Co. KG - Overview
• Exhibit 90: C. H. Boehringer Sohn AG and Co. KG - Business segments
• Exhibit 91: C. H. Boehringer Sohn AG and Co. KG - Key news
• Exhibit 92: C. H. Boehringer Sohn AG and Co. KG - Key offerings
• Exhibit 93: C. H. Boehringer Sohn AG and Co. KG - Segment focus
• 10.5 Ceva Sante Animale
• Exhibit 94: Ceva Sante Animale - Overview
• Exhibit 95: Ceva Sante Animale - Product / Service
• Exhibit 96: Ceva Sante Animale - Key offerings
• 10.6 Dechra Pharmaceuticals Plc
• Exhibit 97: Dechra Pharmaceuticals Plc - Overview
• Exhibit 98: Dechra Pharmaceuticals Plc - Business segments
• Exhibit 99: Dechra Pharmaceuticals Plc - Key offerings
• Exhibit 100: Dechra Pharmaceuticals Plc - Segment focus
• 10.7 Elanco Animal Health Inc.
• Exhibit 101: Elanco Animal Health Inc. - Overview
• Exhibit 102: Elanco Animal Health Inc. - Product / Service
• Exhibit 103: Elanco Animal Health Inc. - Key offerings
• 10.8 Merck KGaA
• Exhibit 104: Merck KGaA - Overview
• Exhibit 105: Merck KGaA - Business segments
• Exhibit 106: Merck KGaA - Key news
• Exhibit 107: Merck KGaA - Key offerings
• Exhibit 108: Merck KGaA - Segment focus
• 10.9 Orion Corp.
• Exhibit 109: Orion Corp. - Overview
• Exhibit 110: Orion Corp. - Product / Service
• Exhibit 111: Orion Corp. - Key offerings
• 10.10 Ouro Fino Saude Animal Group
• Exhibit 112: Ouro Fino Saude Animal Group - Overview
• Exhibit 113: Ouro Fino Saude Animal Group - Product / Service
• Exhibit 114: Ouro Fino Saude Animal Group - Key offerings
• 10.11 Virbac Group
• Exhibit 115: Virbac Group - Overview
• Exhibit 116: Virbac Group - Business segments
• Exhibit 117: Virbac Group - Key news
• Exhibit 118: Virbac Group - Key offerings
• Exhibit 119: Virbac Group - Segment focus
• 10.12 Zoetis Inc.
• Exhibit 120: Zoetis Inc. - Overview
• Exhibit 121: Zoetis Inc. - Business segments
• Exhibit 122: Zoetis Inc. - Key news
• Exhibit 123: Zoetis Inc. - Key offerings
• Exhibit 124: Zoetis Inc. - Segment focus

11 Appendix

• 11.1 Scope of the report
• 11.2 Inclusions and exclusions checklist
• Exhibit 125: Inclusions checklist
• Exhibit 126: Exclusions checklist
• 11.3 Currency conversion rates for US$
• Exhibit 127: Currency conversion rates for US$
• 11.4 Research methodology
• Exhibit 128: Research methodology
• Exhibit 129: Validation techniques employed for market sizing
• Exhibit 130: Information sources
• 11.5 List of abbreviations
• Exhibit 131: List of abbreviations
  • health: Includes veterinary drugs (excluded from the scope of the report)

Exhibits:

• Exhibits1: Executive Summary - Chart on Market Overview
• Exhibits2: Executive Summary - Data Table on Market Overview
• Exhibits3: Executive Summary - Chart on Global Market Characteristics
• Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
• Exhibits5: Executive Summary - Chart on Market Segmentation by Type
• Exhibits6: Executive Summary - Chart on Incremental Growth
• Exhibits7: Executive Summary - Data Table on Incremental Growth
• Exhibits8: Executive Summary - Chart on Vendor Market Positioning
• Exhibits9: Parent market
• Exhibits10: Market Characteristics
• Exhibits11: Offerings of vendors included in the market definition
• Exhibits12: Market segments
• Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
• Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
• Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
• Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• Exhibits17: Five forces analysis - Comparison between 2021 and 2026
• Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
• Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
• Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
• Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
• Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
• Exhibits23: Chart on Market condition - Five forces 2021 and 2026
• Exhibits24: Chart on Type - Market share 2021-2026 (%)
• Exhibits25: Data Table on Type - Market share 2021-2026 (%)
• Exhibits26: Chart on Comparison by Type
• Exhibits27: Data Table on Comparison by Type
• Exhibits28: Chart on Parenteral - Market size and forecast 2021-2026 ($ million)
• Exhibits29: Data Table on Parenteral - Market size and forecast 2021-2026 ($ million)
• Exhibits30: Chart on Parenteral - Year-over-year growth 2021-2026 (%)
• Exhibits31: Data Table on Parenteral - Year-over-year growth 2021-2026 (%)
• Exhibits32: Chart on Oral - Market size and forecast 2021-2026 ($ million)
• Exhibits33: Data Table on Oral - Market size and forecast 2021-2026 ($ million)
• Exhibits34: Chart on Oral - Year-over-year growth 2021-2026 (%)
• Exhibits35: Data Table on Oral - Year-over-year growth 2021-2026 (%)
• Exhibits36: Market opportunity by Type ($ million)
• Exhibits37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits38: Chart on Market share By Geographical Landscape 2021-2026 (%)
• Exhibits39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
• Exhibits40: Chart on Geographic comparison
• Exhibits41: Data Table on Geographic comparison
• Exhibits42: Chart on North America - Market size and forecast 2021-2026 ($ million)
• Exhibits43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
• Exhibits44: Chart on North America - Year-over-year growth 2021-2026 (%)
• Exhibits45: Data Table on North America - Year-over-year growth 2021-2026 (%)
• Exhibits46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibits47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibits48: Chart on Europe - Year-over-year growth 2021-2026 (%)
• Exhibits49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
• Exhibits50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
• Exhibits51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
• Exhibits52: Chart on Asia - Year-over-year growth 2021-2026 (%)
• Exhibits53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
• Exhibits54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibits55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibits56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
• Exhibits57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
• Exhibits58: Chart on US - Market size and forecast 2021-2026 ($ million)
• Exhibits59: Data Table on US - Market size and forecast 2021-2026 ($ million)
• Exhibits60: Chart on US - Year-over-year growth 2021-2026 (%)
• Exhibits61: Data Table on US - Year-over-year growth 2021-2026 (%)
• Exhibits62: Chart on Germany - Market size and forecast 2021-2026 ($ million)
• Exhibits63: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
• Exhibits64: Chart on Germany - Year-over-year growth 2021-2026 (%)
• Exhibits65: Data Table on Germany - Year-over-year growth 2021-2026 (%)
• Exhibits66: Chart on UK - Market size and forecast 2021-2026 ($ million)
• Exhibits67: Data Table on UK - Market size and forecast 2021-2026 ($ million)
• Exhibits68: Chart on UK - Year-over-year growth 2021-2026 (%)
• Exhibits69: Data Table on UK - Year-over-year growth 2021-2026 (%)
• Exhibits70: Chart on Canada - Market size and forecast 2021-2026 ($ million)
• Exhibits71: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
• Exhibits72: Chart on Canada - Year-over-year growth 2021-2026 (%)
• Exhibits73: Data Table on Canada - Year-over-year growth 2021-2026 (%)
• Exhibits74: Chart on China - Market size and forecast 2021-2026 ($ million)
• Exhibits75: Data Table on China - Market size and forecast 2021-2026 ($ million)
• Exhibits76: Chart on China - Year-over-year growth 2021-2026 (%)
• Exhibits77: Data Table on China - Year-over-year growth 2021-2026 (%)
• Exhibits78: Market opportunity By Geographical Landscape ($ million)
• Exhibits79: Impact of drivers and challenges in 2021 and 2026
• Exhibits80: Overview on Criticality of inputs and Factors of differentiation
• Exhibits81: Overview on factors of disruption
• Exhibits82: Impact of key risks on business
• Exhibits83: Vendors covered
• Exhibits84: Matrix on vendor position and classification
• Exhibits85: Bayer AG - Overview
• Exhibits86: Bayer AG - Business segments
• Exhibits87: Bayer AG - Key offerings
• Exhibits88: Bayer AG - Segment focus
• Exhibits89: C. H. Boehringer Sohn AG and Co. KG - Overview
• Exhibits90: C. H. Boehringer Sohn AG and Co. KG - Business segments
• Exhibits91: C. H. Boehringer Sohn AG and Co. KG - Key news
• Exhibits92: C. H. Boehringer Sohn AG and Co. KG - Key offerings
• Exhibits93: C. H. Boehringer Sohn AG and Co. KG - Segment focus
• Exhibits94: Ceva Sante Animale - Overview
• Exhibits95: Ceva Sante Animale - Product / Service
• Exhibits96: Ceva Sante Animale - Key offerings
• Exhibits97: Dechra Pharmaceuticals Plc - Overview
• Exhibits98: Dechra Pharmaceuticals Plc - Business segments
• Exhibits99: Dechra Pharmaceuticals Plc - Key offerings
• Exhibits100: Dechra Pharmaceuticals Plc - Segment focus
• Exhibits101: Elanco Animal Health Inc. - Overview
• Exhibits102: Elanco Animal Health Inc. - Product / Service
• Exhibits103: Elanco Animal Health Inc. - Key offerings
• Exhibits104: Merck KGaA - Overview
• Exhibits105: Merck KGaA - Business segments
• Exhibits106: Merck KGaA - Key news
• Exhibits107: Merck KGaA - Key offerings
• Exhibits108: Merck KGaA - Segment focus
• Exhibits109: Orion Corp. - Overview
• Exhibits110: Orion Corp. - Product / Service
• Exhibits111: Orion Corp. - Key offerings
• Exhibits112: Ouro Fino Saude Animal Group - Overview
• Exhibits113: Ouro Fino Saude Animal Group - Product / Service
• Exhibits114: Ouro Fino Saude Animal Group - Key offerings
• Exhibits115: Virbac Group - Overview
• Exhibits116: Virbac Group - Business segments
• Exhibits117: Virbac Group - Key news
• Exhibits118: Virbac Group - Key offerings
• Exhibits119: Virbac Group - Segment focus
• Exhibits120: Zoetis Inc. - Overview
• Exhibits121: Zoetis Inc. - Business segments
• Exhibits122: Zoetis Inc. - Key news
• Exhibits123: Zoetis Inc. - Key offerings
• Exhibits124: Zoetis Inc. - Segment focus
• Exhibits125: Inclusions checklist
• Exhibits126: Exclusions checklist
• Exhibits127: Currency conversion rates for US$
• Exhibits128: Research methodology
• Exhibits129: Validation techniques employed for market sizing
• Exhibits130: Information sources
• Exhibits131: List of abbreviations